Logo

Oncocyte: Ronnie Andrews, Joshua Riggs, Louis Silverman

Dec 01, 2022

Ronnie Andrews has stepped down as CEO and director of Oncocyte, effective Dec. 1. He will continue as a consultant for the molecular diagnostics firm until Feb. 28, 2023. Joshua Riggs is serving as interim CEO until a permanent CEO has been appointed. Riggs has been Oncocyte's general manager of transplant since July of this year and was previously the firm's senior director of business development. Before that, he was a principal at consulting firm Bethesda Group.

In addition, Louis Silverman has been appointed as an independent member of Oncocyte's board of directors, effective immediately. He is the chairman and CEO of Hicuity Health (formerly Advanced ICU Care), a provider of high acuity telemedicine services. Silverman holds a BA in American studies from Amherst College and an MBA from Harvard Business School.

Breaking News
The Scan

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.

Sequencing Analysis Examines Gene Regulatory Networks of Honeybee Soldier, Forager Brains

Researchers in Nature Ecology & Evolution find gene regulatory network differences between soldiers and foragers, suggesting bees can take on either role.

Analysis of Ashkenazi Jewish Cohort Uncovers New Genetic Loci Linked to Alzheimer's Disease

The study in Alzheimer's & Dementia highlighted known genes, but also novel ones with biological ties to Alzheimer's disease.

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.